(Q37109079)

18 August 2017

1 reference

title

Drug nanoparticles: formulating poorly water-soluble compounds (English)

1 reference

18 August 2017

0 references

Elaine M Merisko-Liversidge

series ordinal

1

1 reference

PubMed ID

18337220

18 August 2017

Gary G Liversidge

series ordinal

2

1 reference

PubMed ID

18337220

18 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

18 August 2017

Toxicologic Pathology

1 reference

18 August 2017

36

1 reference

18 August 2017

1

1 reference

18 August 2017

43-48

1 reference

Lipid emulsions as drug delivery systems

18 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

Organic Nanoparticles in the Aqueous Phase-Theory, Experiment, and Use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

Microemulsion formulation for enhanced absorption of poorly soluble drugs. I. Prescription design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

The pharmacokinetics of nebulized nanocrystal budesonide suspension in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

Nanosuspension formulations for low-soluble drugs: pharmacokinetic evaluation using spironolactone as model compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

Drug-like properties and the causes of poor solubility and poor permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

Designing dendrimers for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

Nanosizing: a formulation approach for poorly-water-soluble compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

Insulin nanoparticles: a novel formulation approach for poorly water soluble Zn-insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

Liposome formation and properties: an evolutionary profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

Nanosuspensions in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

Indirect computed tomography lymphography using iodinated nanoparticles to detect cancerous lymph nodes in a cutaneous melanoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307310946

21 January 2018

Identifiers

DOI

10.1177/0192623307310946

1 reference

18 August 2017

1 reference

PubMed ID

18337220